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Simple Summary: The use of chemotherapy drugs against tumours is associated with various
drawbacks such as poor solubility, low stability, high toxicity, lack of selectivity and rapid clear-
ance. Nanocarriers can improve the safety and efficiency of drugs by increasing their solubility,
enhance their circulation time and improve their uptake into cancer cells. Natural materials can
be incorporated in the fabrication of nanocarriers as a substitute to synthetic ingredients. Several
studies developed different types of green based nanocarriers using materials obtained from plant or
microbial sources such as polysaccharides and polyphenols without the need of toxic chemicals in
the synthesis. The green components can have many roles for example as mechanical support, trigger
pH response for drug release, or act as a targeting ligand. The inclusion of these green components
will support the cost effective and feasible large-scale production of nanocarriers with minimum
negative impact on the environment.
Abstract: The use of nanocarriers for biomedical applications has been gaining interests from re-
searchers worldwide for the delivery of therapeutics in a controlled manner. These “smart” vehicles
enhance the dissolution and the bioavailability of drugs and enable their delivery to the target
site. Taking the potential toxicity into consideration, the incorporation of natural “green” materials,
derived from plants or microbial sources, in the nanocarriers fabrication, improve their safety and
biocompatibility. These green components can be used as a mechanical platform or as targeting
ligand for the payload or can play a role in the synthesis of nanoparticles. Several studies reported
the use of green based nanocarriers for the treatment of diseases such as cancer. This review article
provides a critical analysis of the different types of green nanocarriers and their synthesis mecha-
nisms, characterization, and their role in improving drug delivery of anticancer drugs to achieve
precision cancer treatment. Current evidence suggests that green-based nanocarriers can constitute
an effective treatment against cancer.
Keywords: green nanotechnology; nanocarriers; drug delivery system; plant extracts; polysaccha-
rides nanoparticles; microorganism-based nanoparticles; anticancer activity
1. Introduction
Nanotechnology is an interdisciplinary field of science concerned with the processing
of matter at atomic/molecular level [1]. Nanotechnology is applicable in many areas such
as the chemical industry, pharmaceutical industry, optics, electronics, energy science and
biomedical sciences [2]. The size of the nanoparticles (NPs) is comparable to the size of
proteins and various intracellular macromolecules, which allows them to take advantage of
cellular machinery to assist in the drug delivery [3]. Additionally, in comparison to bulky
materials, NPs have large surface to volume ratio allowing for chemical modifications
to tune their properties [4]. NPs can be used as nanocarriers to encapsulate drugs or
biomolecules inside their structures and/or absorb them on their surfaces. There are
different types of nanocarriers including polymeric NPs, liposomes, micelles, dendrimer,
hydrogel, mesoporous, 0, 1 and 2-D materials [5]. These types are broadly divided into
organic, inorganic and hybrid nanocarriers [6]. Several types of payloads can be delivered
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using NPs such as conventional drugs, polypeptides, proteins, vaccines, nucleic acids,
genes, etc. [7].
The commonly used conventional chemotherapies include alkylating agents, antitu-
mour antibiotics (e.g., epirubicin, doxorubicin (DOX)), antimetabolites (e.g., 5-fluorouracil
(5-FU), methotrexate, gemcitabine), topoisomerase inhibitors, and mitotic inhibitors (e.g.,
paclitaxel and docetaxel) [8]. Chemotherapy drug delivery for local and metastatic tumours
is associated with various drawbacks. Such problems may include high toxicity in normal
cells, lack of tumour target selectivity, high volume drug distribution and rapid drug
clearance [9]. Nanocarriers can improve the safety and efficiency of drugs by increasing
their water solubility and stability, enhance their circulation time, improve their uptake
by targeted cancer cells or prevent their enzyme degradation [10]. The current reports
on the use of nanocarriers for drug delivery focus on: (1) the choice of suitable carrier
materials to achieve high drug encapsulation rate and controlled and targeted release
speed; (2) improvement of targeting ability via surface functionalization; (3) augmentation
of drug biological activity with using carrier materials of similar activity; (4) formulating
responsive nanocarriers that are able to release the loaded drugs at designated sites in a
response to the local environment (e.g., pH-response release and response to enzymatic
degradation of nanocarriers, etc.); (5) performing in vitro and in vivo assays to compare
the biological activity between the loaded drugs and their free forms and to assess the
safety of the nanocarriers and their stability. The use of nanocarriers inside the body will
allow them to interact with blood components and vessels, normal tissues, etc., meaning
that they can influence human health and therefore it is important to consider the safety of
the components included in the synthesis of these nanomaterials. Despite advancements
in nanocarriers, their transformation in medical applications remains insufficient. This
mainly is due to their lack of biodegradation, instability in circulation, poor bioavailability,
long-term potential toxicity, and inadequate tissue distribution.
Therefore, the overall aim of including green components in the fabrication of NPs as
nanocarriers is to decrease toxicity to the body, to have an environmentally benign industry
process and to increase affordability. The green synthesis may be facilitated by plants
extracts and microbes or their isolated biomolecules [11]. The green based nanocarriers are
mainly synthesized by the bottom-up approach within three fundamental conditions of
synthesis. These conditions are based on the selection of a green non-toxic solvent, coupled
by a good reducing agent, and thirdly incorporating an efficient stabilization material.
In this review, we will highlight different examples of green based nanocarriers used
in the drug delivery of conventional anticancer drugs that contain a plant or microbial-
derived components in their formulation. The review will highlight the role of the different
green component used in the synthesis or in the drug delivery mechanism. In addition
to the safety of using these green components, the review will also include the various
benefits and the advantages of using each type of the green components.
2. Green Components in Nanocarriers for Anticancer Therapy
2.1. Polysaccharides-Based Nano Delivery Systems
Unlike petroleum-based polymers, the natural biopolymers are extensively used in
agricultural, environmental and medical industries due to their nontoxic and sustainable
properties [12]. An example of biopolymeric compounds are polysaccharides which are
polymers of monosaccharides connected via glycosidic bonds and can be acquired from
animals (e.g., chitosan, chondroitin), plants (e.g., cellulose), seaweed (e.g., carrageenan
(CR)) and microorganisms (e.g., alginate, pullulan) [13,14]. Chemically, polysaccharides
differ in charge, chain length, the sequence of the monosaccharides and stereochemistry,
which render them useful in the preparation of functionalized materials for biomedical
applications [15]. Polysaccharides can reduce and stabilize metal salts for the synthesis of
metallic nanoparticles (MNPs). In addition, the presence of hydrophilic functional groups
(e.g., -OH, -COOH, -NH2) in their structures enables them to establish non-covalent bonds
with biological cells and to form bioadhesive polymers that can improve the efficacy of
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different drugs [15]. Polysaccharides also play an important role in cell-to-cell recognition
and have selectivity to more than one site, which makes them useful in formulating drug
delivery systems against multi-gene and multi-step diseases such as cancer.
Chen et al. (2019) used CR oligosaccharides (obtained from the hydrolysis of CR)
as bio reducing and stabilizing material for the synthesis of spherical gold nanoparticles
(GNPs). The negatively charged NPs were used as carriers for the positively charged
anticancer drug, epirubicin. The (CR oligosaccharides/GNPs/epirubicin) nanosystem
showed significantly lower IC50 value (0.087 ± 0.036 µmol/L) than the free epirubicin
(0.173 ± 0.043 µmol/L) against human liver cancer cells (HepG2) as determined by the
sulforhodamine B colorimetric assay. The average size of this nanocarrier was found
to be 141 ± 6 nm, which could facilitate the uptake of the nanocarrier in cancer cells via
endocytosis. The confocal imaging technique confirmed the uptake of the loaded epirubicin
in the DAPI stained human colon cancer cells (HCT-116) as shown by the presence of red
fluorescence in the cytoplasm and the nucleus. Interestingly, the red fluorescence produced
after incubating the cells with the nanocarrier was more intense than the red fluorescence
formed from the free epirubicin, indicating higher uptake of the loaded epirubicin [16].
The work done by Pavli et al. (2011) also exploited the electrostatic interaction between the
anionic CR and the cationic properties of another anticancer drug, doxazosin [17].
One study explored the use of magnetic CR and chitosan as a hydrogel nanocomplex
for the drug delivery for methotrexate [18]. The authors first synthesized iron oxide
nanoparticles (Fe3O4 NPs) in the presence of CR. The produced magnetic CR was then
allowed to perform electrostatic bond with protonated chitosan to give a hydrogel. The
swelling studies showed that water absorbency of the hydrogel was decreased by the
presence of magnetic NPs and by increasing the amount of chitosan. This was attributed to
the hydrogen bonding between the Fe3O4 NPs and the CR/chitosan complex and to the
increase in the electrostatic interactions between the complex components. The magnetic
hydrogel was then utilized as a carrier for methotrexate. The encapsulation of methotrexate
was higher by over 60% when increasing the magnetic NPs and chitosan contents. The
drug release study was done in different pH buffers that mimic the blood (pH 7.4) and
intracellular conditions of cancerous cells (pH 5.3). Methotrexate showed higher release at
pH 7.4 (almost 70%) after 4 hr, and slower release (around 50%) at pH 5.3 at the same time.
Jafari et al. (2021) performed a similar work of crosslinking the chitosan and CR but
with incorporating nanoplates of magnetic montmorillonite (m-MMt) to acquire more
mechanically stable hydrogel with enhanced drug release control in order to minimize the
adverse effects of anticancer drugs (Figure 1). CR was allowed to form electrostatic bond
with the m-MMt, the mixture was loaded with sunitinib as an anticancer drug model. The
resulted composite was later coated with chitosan facilitated by the interaction between the
protonated amine group of chitosan with the anionic sulphate group of CR. The loading of
sunitinib and its controlled released was found to be improved by increasing the amount
of m-MMt used. The reason for this is the strong interaction between the cationic nature
of sunitinib and the anionic core of the m-MMt as well as the high surface area of the
m-MMt [19].
Yew et al. (2020) combined the solutions of CR (as a stabilizer), montmorillonite
(MMt) (as a mechanical support) and Fe3+/Fe2+ chloride salts in an alkaline environment
to formulate CR/MMt/ F3O4 NPs nanocomposite. The anticancer drug, protocatechuic
acid, was loaded into the nanocomposite and exhibited release rate of 92% at pH 4.8 and
15% at pH 7.4. The free drug had a release rate higher than 85% at both pH levels, which
shows the potential targeting effect of this nanocomposite [20].
The use of plant derived gum in the synthesis of NPs was also studied for their
biocompatibility and non-toxic nature as opposed to the organic solvents. Gum karaya,
obtained from the Sterculia plant species, was reported in the reduction and stabilization
of GNPs in which several reaction parameters such as time, temperature, gum and gold
salt concentrations and ratios were selected to obtain NPs with desired physicochemical
properties. The results from the MTT assay on human lung cancer cells (A549) showed
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that the gum karaya/GNPs loaded with gemcitabine hydrochloride induced lower cell
viability (35.1% at 1.0 µg/mL) than the free drug at the same concentration (46.8%). It has
been shown that the anticancer mode of action of gemcitabine hydrochloride includes the
ROS generation in the cancer cells [21]. The authors found that the ROS generation levels
were significantly higher after treating the cells with the loaded gemcitabine hydrochloride
in comparison to its free form [22].
Figure 1. A diagram showing the synthesis of m-MMt (a), and the m-MMt/CR/chitosan hydrogel (b).
Reproduced from [19].
Godugu and beero (2018) loaded 5-FU into platinum nanoparticles (PtNPs) syn-
thesized and stabilized using gum kondagogu, a natural anionic gum from the Indian
Cochlospermum Gossypium (Family: Bixaceae). The authors observed the UV-Vis of the gum
kondagogu and platinum salt solution mixtures at different conditions and selected pH 8.0
and heating at 100  C as the best reaction parameters. Further, the NPs exhibited sustained
release of the 5-FU. The authors used dialysis bag to measure the drug release % and the
HPLC profiling indicated the sustained release of the loaded 5-FU (67.3 ± 0.2%) compared
to 92.9 ± 0.5% of the free 5-FU in 120 min. The authors also utilized the Agrobacterium
tumefaciens-induced potato disc tumour assay to evaluate the cytotoxicity of the loaded
and free 5-FU. The 5-FU loaded in the nanocarrier showed complete tumour inhibition at
concentration of 30 µg/mL, whereas 60 µg/mL of the free 5-FU was needed to completely
inhibit the tumour [23].
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The bacterial derived gellan gum is another anionic polysaccharide that was em-
bedded with a silkworm protein, sericin, and the rice bran albumin to form a green
protein-polysaccharide nanocomposite which was loaded with DOX [24]. This nanocom-
posite was pH responsive due to the presence of sericin while the rice bran albumin was
used to release the loaded DOX in a controlled matter. The nanocomposite showed a
swilling rate of 72% and 32% after 40 h at acidic and basic pH, respectively. This shows the
ability of the nanocomposite to induce sustained release in the tumour environment [24]. A
previous work utilized the reducing properties gellan gum to synthesize GNPs which did
not show any significant UV-Vis alterations under wide range of pH (3.0–10) and electrolyte
conditions (NaCl 0.1 M). The gum-based GNPs were loaded with DOX, which showed
significant cytotoxicity against glioma cell lines (LN-18 and LN-229) more than the free
DOX. The confocal microscopy images showed that the DOX loaded on the gum-based
GNPs induced cell death via apoptosis (Figure 2) [25].
Figure 2. Confocal microscopy images showing DAPI stained cells ((A) LN-18 and (B) LN-229) demonstrating the apoptotic
effects of DOX loaded on the gum-based GNPs (denoted DOX-AuNPs). Reproduced from [25].
Maltodextrin, an (1,4)-glucose polymer, is water soluble and can be used as hydrophilic
carrier for pharmaceutical active ingredients, and can be obtained by the partial hydrolysis
of starch [26]. A study reported the preparation of polysaccharide NPs composed of gum
Arabic and maltodextrin functionalized with epigallocatechin-3-gallate (EGCG). It was
demonstrated by the clonogenic assay that encapsulated EGCG had enhanced inhibitory ef-
fect on human androgen independent prostate cancer cells (DU145) at lower concentrations
compared to the pristine EGCG [27].
Porphyran is a linear sulphated polysaccharide obtained from the red algae Porphyra
sp. with reported anticancer properties [28,29]. The synthesis of GNPs using porphyran
as a reducing and capping agent was done at pH 11 and with heating at 70  C. DOX was
loaded on the produced GNPs leading to the increase of the zeta potential due to the
positive charge of DOX. The cytotoxicity evaluation against LN-229 showed that the loaded
DOX was four times toxic than its free form, which was attributed to the increased uptake
of the loaded DOX via endocytosis. Further, the porphyran GNPs enabled controlled of
the payload with the amount of DOX released was six times at acidic pH compared to the
basic pH condition [30].
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Several research articles reported the use of cyclodextrin (CD) in the formation of
polysaccharides-based NPs. CD (also known as macrocyclic receptors) are key players in
drug delivery because they can bind non-covalently to drugs, are biocompatible and have
high resistance to non-enzymatic degradation with high thermal and chemical stability,
making them particularly useful for drug delivery through oral routes [31].
Zhang et al. (2014) used CD and graphene oxide nanosheets as a scaffold to load
hyaluronated adamantane (as a hyaluronic acid (HA) receptor targeting ligand) and the
poorly soluble anticancer, camptothecin. The authors factionalized the graphene oxide
sheets with CD using amine-epoxy reaction before loading the targeting ligand and camp-
tothecin non-covalently. The in vitro cytotoxicity assay revealed that the tertiary assembly
induced higher cytotoxicity against MDA-MB-231 (human breast cancer cells with high ex-
pression of HA receptors) with around 51.5% viability compared to 64.5% viability recorded
after incubation the cells with the free camptothecin. The cytotoxicity of the nanocomposite
was lower (82.5%) after the incubation with normal fibroblast cells compared to the free
drug (63.0%) indicating the selectivity of nanocomposite towards the cancer cells [32].
The size and crystallinity of the CD metal-framework were optimized for the first-time
using seed-mediated synthesis with starch NPs and also by controlling incubation time.
This framework showed relatively small in vitro cytotoxicity and were also used to increase
the stability and induced controlled release of resveratrol [33].
The natural and non-immunogenic, alginate, is readily available and biodegradable
anionic polymer [34]. The backbone of this marine algae isolate has hydroxyl groups that
can reduce gold salts into GNPs. Additionally, the carboxylic groups found in its structure
can play a role in the stabilization of the GNPs [35].
Dey et al. (2016) used alginate and curcumin conjugate to synthesize and stabilize
GNPs and was subsequently loaded with methotrexate covalently after the conjugation
with bis(aminopropyl) terminated polyethylene glycol (PEG). This dual drug (curcumin
and methotrexate) biopolymer showed enhanced cytotoxicity effect against rat glioma (C6)
and human breast cancer (MCF-7) cell lines in comparison to the free drugs. The authors
related this enhanced activity of the biopolymer to its suitable hydrodynamic size (187 nm),
the negatively charged GNPs and the hydrophilic corona protection (alginate and PEG)
that enabled the NPs to avoid reticuloendothelial system clearance and acquire enhanced
permeation and retention effect (Figure 3) [36].
Figure 3. The effect of free curcumin (denoted Ccm) and the loaded curcumin on the nanocarrier (denoted MP@Alg-Ccm
AuNPs) of the cell viability of (A) C6 and (B) MCF-7 cells as established by the MTT assay. Reproduced from [36].
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Pullulan is another polysaccharide that is produced by the Aureobasidium pullulans fun-
gus [37]. The low viscosity and high-water solubility of this polymer give it an advantage
over other polysaccharides (e.g., CR, chitosan and cellulose) that would require further
derivatization making them unsuitable for large-scale synthesis [38].
A study reported an easy methodology of the biosynthesis of GNPs from alkali treated
pullulan with the aid of its hydroxyl groups. The authors optimized different reaction
parameters to control the morphology of the biocompatible GNPs. The study also reported
the loading two cassiarin A chloride derivatives as anticancer drug models which showed
higher toxicity against human gastric carcinoma cells (KATO-III) compared to their free
forms and the positive control cisplatin [39]. The same authors also used a derivatised
pullulan (with para-aminobenzoic acid-quat188-pullulan) for the synthesis of GNPs. This
functionalization allowed a better intramolecular interaction and stronger interaction with
negative charged cancer cell facilitated by the positively charged quat188 and hydrophobic
attraction of para-aminobenzoic acid with the hydrophobic sections of the cells. This was
demonstrated by the two times higher cytotoxicity of the DOX loaded into these GNPs
compared to the free DOX against Chago cells [40]. In a continuation of the same work, the
authors decorated the same DOX loaded Pullulan derivatised GNPs with folate (FA) to
enhance its targeting effect, which yielded around five-fold higher cytotoxicity compared
to the pristine drug against Chago cells. This increase in the cytotoxicity was mainly
attributed to the targeting effect of FA to the overexpressed folate receptors on the Chago
cells [41].
Carboxymethylcellulose (CMC) is a water-soluble anionic biopolymer cellulose deriva-
tive that is non-hazardous, biodegradable, and renewable with pH-sensitivity making it
excellent for drug delivery systems [42].
A nanocomposite composed of CMC/Zinc/graphene oxide was synthesized with
a facile one-pot method using solvothermal technique. The nanocomposite was loaded
with DOX and showed minimal release of the drug under normal physiological condi-
tions. Interestingly, the drug release of DOX from graphene oxide nanosheets without the
CMC/Zinc framework was higher under the same conditions. which shows the potential
of the nanocomposite to minimize the side effects of DOX on normal tissues. Conversely,
the release of DOX at pH 5 from the nanocomposite was higher than its release from the
graphene oxide alone, citing the role of nanocomposite in minimizing the side effects
of DOX against normal tissue and in increasing its targeting effect against cancer tissue.
Similarly, the cytotoxicity of CMC/Zinc/graphene oxide nanocomposite loaded with DOX
was higher than graphene oxide loaded with DOX against human blood cancer cell line
(K562). This increased cytotoxicity was explained by the positive charge of the nanocom-
posite, which can be attracted to the cancer cells. However, the free DOX induced higher
cytotoxicity than the loaded DOX which the authors contributed to the sustained release
from the nanocomposite [43].
Sun et al. (2019) reported the formation of CMC and chitosan pH responsive nanocom-
posite in order to eliminate their individual limitations in delivering drugs in gastroin-
testinal environment. The nanocomposite was also coupled with zinc oxide nanoparticles
(ZnONPs) to assist in burst release prevention. The 5-FU was used as a drug model, which
exhibited greater adsorption into the nanocomposite by increasing the CMC quantity
because of the attraction between the carboxyl groups of CMC and the hydroxyl and
amine groups of 5-FU. The swelling rate was found to be minimum at pH 1.2 making the
nanocomposite suitable for oral drug delivery in the treatment of colon cancer [44]. Poores-
maeil et al. (2019) also used CMC to prevent the gastric burst release of 5-FU entrapped in
layered double hydroxide of zinc and aluminium [45].
CMC was also used for the first time to cap fluorescent quantum dots composed of Cu-
In-S/ZnS for theranostic purposes. In the following, the CMC stabilized quantum dots were
functionalized with FA and DOX. The cytotoxicity assays recorded lower antiproliferative
properties against the FR↵—HEK 293T and MCF-7 cells compared to the unbound DOX.
This was attributed to the sustained release by the polymeric quantum dots that can be
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taken up by the cells via endocytosis, whereas the free drug can also infiltrate the cells by
diffusion. However, the loaded DOX showed 30% higher cytotoxicity than the free DOX
towards the FR↵ + TNBC cells, facilitated by the presence of FA in the quantum dots. The
confocal laser microscopy images revealed the DOX was mainly internalized in the nucleus
causing cell death by intercalating with the DNA and affecting the cell metabolism [46].
Similar work also used CMC as a stabilizer for Bi2O2CO3 quantum dots that were used to
load sorafenib for liver cancer drug delivery. The dialysis analysis showed over 77% drug
release in case of loaded sorafenib and only 2.47% drug was released from the sorafenib
control solution [47].
2.2. Plant Extracts-Based Nanocarriers
The use of plant extracts in the biosynthesis of different types of NPs has been widely
explored due to their availability, renewability, easy and safe handling compared to other
green routes such as bacteria or fungi. The presence of effective phytochemicals with
different functional groups such as ketones, aldehydes, flavones, amides, terpenoids,
carboxylic acids, phenols, and saponins can reduce metal salts into MNPs without the need
for chemical stabilizers/capping agents.
Biodegradable poly(D,L-lactide) NPs were synthesized using five plant extracts
namely, Syzygium cumini, Bauhinia variegata, Cedrus deodara, Lonicera japonica and Eleaocarpus
sphaericus as stabilizers and emulsifiers. The synthesis was done by sonicating poly(D,L-
lactide) solution with dichloromethane and the aqueous plant extract. The transmission
electron microscopy (TEM) analysis showed that the produced poly(D,L-lactide) NPs are
spherical in shape and with different average sizes depending on each plant extract used.
The poly(D,L-lactide) NPs from Lonicera japonica were uniform and therefore were selected
for the loading of quercetin as a model for delivery of anticancer drug. The loading of
quercetin was confirmed by the reduction of its absorption at 350 nm. The in vitro release
study using phosphate buffer showed a burst release of around 20–27% of quercetin in
30 min, followed by controlled release of 32% after 24 h [48]. Similar study reported the
green synthesis of PLGA NPs in a solvent-free method using castor oil derivative (acrysol
oil). The study also incorporated resveratrol into the green PLGA-NPs which showed
enhanced cytotoxicity against MCF-7 cells [49].
Mukherjee et al. (2012) used the aqueous extract of Eclipta alba to formulate spherical
GNPs. The synthesis was optimized using different volumes of the plant extract. The
GNPs showed efficient in vitro stability when incubated with different buffer and biological
solutions. The biosafety of the GNPs (up to 114 µM) was shown by maintaining the viability
of MCF-7 and MDA-MB-231 after 48 h incubation. However, 10 µM of the GNPs loaded
with DOX exhibited 50% cell viability reduction of MCF-7 cells after the same period [50].
Biocompatible GNPs and silver nanoparticles (AgNPs) were synthesized using the
leaf aqueous extract of Butea monosperma. The reaction was optimized by varying the leaf
extract volume and keeping the volume of the gold and silver salts unchanged, which
produced NPs after 5 min and 2 h for GNPs and AgNPs, respectively (Figure 4). The study
reported the use of AgNO3 staining to confirm that low molecular weight proteins content
of B. monosperma were responsible for the synthesis and stabilization of the produced
MNPs. Dynamic light scattering (DLS) analysis confirmed the conjugation of DOX into
the biosynthesized GNPs and AgNPs with the increase in their hydrodynamic size. Both
MNPs loaded with DOX exhibited higher cytotoxicity compared to the pristine drug
against mouse melanoma (B16F10) cells. Further, the fluorescence microscopy indicated
higher red fluorescence in case of the DOX loaded into the MNPs compared to the free
DOX, this proves higher internalization of DOX inside the B16F10 cells when loaded into
the MNPs [51].
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Figure 4. The characterization of the MNPs showing the X-ray diffraction peaks (a,b) confirming the crystallinity of the
GNPs (denoted b-Au-500) and AgNPs (denoted b-Ag-750) from B. monosperma. c-f are the TEM images of the GNPs and
AgNPs synthesized using different volumes of the B. monosperma extract 250 µL (c), 500 µL (d) for GNPs and 500 µL (e),
750 µL (f) for AgNPs). Reproduced from [51].
DOX was also loaded into GNPs biosynthesized using the aqueous extract of Peltopho-
rum pterocarpum. The study explored the cytotoxicity of the loaded DOX in mice injected
with B16F10 cells. The results displayed a substantial time-dependent reduction of the
tumour volume in the mice treated with the loaded DOX-GNPs in comparison the free
DOX treated mice [52].
The eggplant fruit extract was also reported in the reduction and stabilization of
GNPs using the irradiation of natural sunlight. The produced GNPs were functionalized
wit HA as a targeting agent. The carboxylic groups of HA were activated by 1-ethyl-
3-(3-dimethylaminopropyl) carbodi-imide and N-hydroxysulfosuccinimide to allow its
conjugation with the amid groups of the anticancer drug, metformin. The release of the
loaded metformin was found to be negligible at higher pH, citing the targeting effect of
the nanocarrier. Moreover, the loaded metformin showed higher cytotoxicity compared
to the free drug. The MTT results after 48 h gave IC50 value of 4 µg/mL against HepG2
cells for the loaded metformin compared to 10 µg/mL for the free drug. The authors used
the acridine orange and ethidium bromide staining experiment and showed that loaded
metformin induce cell death via apoptosis. Interestingly, the same experiment showed
no change on the viability of mouse embryonic fibroblast (NIH 3T3) cells, which was
attributed to the targeting effect of HA to the cluster determinant receptor (CD-44) that is
expressed on HepG2 but not on NIH 3T3 cell line [53].
Ganeshkumar et al. (2013) reported the use of fruit peel extract of Punica granutum
(pomegranate) in the synthesis of stable GNPs. The authors coupled FA as targeting ligand
and the coupling was confirmed by a red shift in the UV-Vis spectrum of the GNPs. After, 5-
FU was loaded into the GNPs, which was shown by the quenching of the 5-FU fluorescence.
It was also found that the nanocarrier was safe up to concentration of 750 µg/mL by
evaluating the morphology, hatching and survival rate of the Zebrafish embryos. To utilize
the targeting effect of FA against breast cancer, the cytotoxicity of nanocarrier loaded with
the 5-FU was done against MCF-7 cell line and the MTT results gave IC50 value (250 ng/mL)
three times lower than the IC50 value of the free 5-FU (1000 ng/mL). The Western blot
analysis has confirmed that nanocarrier loaded with 5-FU induced apoptosis via G0/G1
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cell cycle arrest [54]. The 5-FU loaded on GNPs formulated from the Borassus flabellifer fruit
extract also showed higher cytotoxicity against the pancreas cancer MiaPaCa-2 cell line
than free 5-FU as exhibited by the MTT assay [55].
Almond seed water extract was also used to biosynthesize GNPs. The biosynthesized
GNPs were capped using polyethylene glycol 9000 (PG9) before the functionalization
with quercetin as an anticancer drug model. The MTT results against MCF-7 showed
that only the biosynthesized GNPs functionalized with PG9 and quercetin induced cell
death, whereas quercetin alone and the green GNPs without PG9 or quercetin did not show
significant antiproliferative activity [56].
The biosynthesis of AgNPs was also reported using the fruit water extract of the
Indonesian Garcinia mangostana. The optimization was done by changing the concentration
of AgNO3, temperature and the pH conditions. The loading of protocatechuic acid on the
AgNPs resulted in significant antiproliferation activity (80%) against HCT116 colorectal
cells compared to (5%) from the free AgNPs at concentration of 15.6 µg/mL. The IC50 of
the free protocatechuic acid was 15 times higher than the IC50 of the loaded protocatechuic
acid against the same cell line. The authors found that the cytotoxicity of the AgNPs loaded
with protocatechuic acid was attributed to the loss of mitochondria’s membrane potential
and the generation of ROS [57].
Cai et al. (2020) reported the synthesis of magnetic nanocomposites of Fe3O4 NPs facil-
itated by Euphorbia cochinchensis leaf extract. The resulted NPs were then incorporated with
mesoporous silica and modified with carboxyl groups to prevent their agglomeration. The
green nanocomposites were then loaded with DOX and showed high release at acidic pH.
With the aid of external magnetic field, the authors concluded that these nanocomposites
could be utilized for targeted and controlled release of DOX at tumour site [58].
The synthesis of ZnONPs was also facilitated by the tea ethanolic extract. The NPs
were then loaded with chitosan to facilitate the targeting effect and were then loaded with
paclitaxel. The nanocarrier showed selective toxicity against MCF-7 cells with minimum
effect on normal fibroblasts compared to the free paclitaxel [59].
2.3. Plant Polyphenols and Pospholipids-Based Nanocarriers
Plant-based polyphenols are water soluble amphiphilic polymers which are found
abundantly in nature. These polymers contain many phenolic hydroxyls in their struc-
tures that increase their reactivity towards several metal ions including Au3+, Ag+1, Fe3+,
etc. [60–62]. Plant polyphenols are highly considered for the synthesis of MNPs for the
following reasons: First, the reductive phenolic hydroxyls of plant polyphenols enhance the
water-solubility of the MNPs and prevent their decomposition by oxygen atmosphere [63].
Secondly, the plant polyphenols protect the MNPs from aggregation due to the presence of
hydrophobic and rigid backbones in their structures [64].
Jiang et al. (2019) exploited the reducing capabilities of green tea’s polyphenols to
produce gold nanoclusters (GNCs) suitable for photothermal treatment. The clusters were
loaded with DOX and showed enhanced cytotoxicity activity against B16F10 cells, in which
the cell viability results recorded from MTT assay were 12.1 ± 3.1 and 14.3 ± 0.5% for the
loaded and free DOX, respectively. However, the cell viability induced by the GNCs-DOX
was reduced to 7.7 ± 0.1% when using laser at 808 nm [65].
Another study reported the biosynthesis of graphene oxide using tea polyphenols
for the delivery of DOX. The biosynthesized graphene oxide led to enhanced cytotoxicity
of DOX against human adenoid cystic carcinoma (ACC2) cell line by delivering it to the
nuclei [66].
Black tea polyphenols were also suggested to take a role in the synthesis of carbon
nanoparticles (CNPs) as shown by the UV–Vis absorption and fluorescence spectra of the
produced CNPs. The CNPs were found to escape the lysosomal degradation, which can
assist in the delivery of drugs. The CNPs were then functionalized with DOX, which showed
a reduction of tumour volume in vivo more than free DOX, with no negative effect on the
mice health as indicated by their stable weight throughout the experiment (Figure 5) [67].
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Figure 5. (A) The effect of different concentrations of CNPs loaded with DOX (in mg/mL) on mice
weight at different time intervals. (B) The tumour volume reduction after treating the mice with
3 mg/mL of CNPs loaded with DOX (denoted Cdoxo) and free DOX (denoted Doxo), treatment times
are indicated by the arrows. * p value < 0.05. (C) Weight of the treated mice with similar regimen as in
(B). T0/Tn is the parameter at the zero time over the time on day as illustrated. Reproduced from [67].
Resveratrol (3,40,5-trihydroxy-trans-stilbene) is a natural polyphenol, which is exten-
sively reported with anticancer activity [68–70]. The synthesis of GNPs from resveratrol as
a nanocarrier was reported in a simple one pot method. The produced GNPs was mixed
with aqueous solution of DOX for loading purposes. Testing the anticancer properties
of the DOX-GNPs complex against two human cervical cancer cells (HeLa and CaSKi)
showed reversal of chemoresistance towards the DOX treatment [71].
Furthermore, the amphiphilic nature of the plant-polyphenols make them suitable
for protein binding [72]. For example, a targeting nanogel comprised of HA (to target
CD44 receptor in cancer cells) and EGCG (to bind to protein) was assembled for the
intracellular delivery of granzyme B. The study reported the increased cytotoxicity against
CD44 presenting HCT-116 cells indicating the potential use of HA and EGCG as protein
carriers for cancer treatment [73]. In a similar study, the self-assembly of EGCG and HA
was also explored for the delivery of cisplatin. EGCG was used to encapsulate cisplatin
via hydrophobic interaction, to augment its cytotoxicity and to reduce its side effects [74].
The affinity of EGCG to proteins enabled its conjugation with bovine serum albumin (BSA)
to form a nanosphere intended for drug delivery of DOX [75]. The structure of BSA can
interact with trypsin and glutathione, which are overexpressed by cancer cells [76,77],
making the nanocarrier responsive to these biomarkers and increase its targeting effect.
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Phospholipids are widely used raw materials for pharmaceutical products. They are
included in several types of formulations, such as emulsions, micelles, suspensions, and
liposomal preparations. These natural amphiphilic compounds are basic composition of bio-
logical membranes and are effective alternative to synthetic emulsifiers [78]. Phospholipids
can be glycerophospholipids such as phosphatidylcholine, phosphatidylethanolamine,
phosphatidylinositol and phosphatidylserine or can occur as sphingolipids [79]. Natural
phospholipids can be isolated from dairy products and egg yolk, or from plant sources
such as soybean and rapeseed lecithin and canola oil [80].
Liao et al. (2016) reported the use of EGCG in the preparation of nanoethosomes
for transdermal delivery of docetaxel. The basic nanoethosomes were prepared using
2% soybean phosphatidylcholine, 30% ethanol, 1% Tween-80 and 0.1% sugar esters. The
loading of 0.2% EGCG (w/w) into these nanoethosomes increased their stability. The EGCG-
nanoethosomes also showed efficient skin penetration reaching the hypodermis, whereas
the basic-nanoethosomes were only located in the dermis and epidermis as exhibited by
confocal laser microscopy. Docetaxel was then loaded into the EGCG-nanoethosomes
and its antitumor activity was evaluated against human melanoma cancer cells (A-375)
implanted in mice skin. The EGCG-nanoethosomes loaded with docetaxel led to a signifi-
cant reduction in the tumour size in comparison to the basic-nanoethosomes loaded with
docetaxel [81].
The effectiveness of DOX was also enhanced by loading it on liposomes made of two
layers of phospholipids of lecithin and N-trimethyl chitosan. The liposomes exhibited
variable vascular targeting ability on human umbilical vein endothelial cells by altering
the degree of quaternization of chitosan used. The loaded DOX also showed enhanced
anticancer activity against hepatoma cells (H22) implanted on mice [82].
Zhang and co-workers (2017) developed liposomes made of phospholipids coating
mesoporous carbon matrix for the oral delivery of the poorly soluble, docetaxel. The
authors used carboxymethyl chitosan to protect the liposomes from the gastric pH. The
incorporation of phospholipids and was found to increase the sustained release effects of
the liposomes. Additionally, the carboxymethyl chitosan and phospholipids layers were
shown to reduce the toxicity of mesoporous carbon matrix, which can lead to increased
biocompatibility [83].
2.4. Microorganisms-Based Nanocarriers
The use of cells as drug delivery systems has been studied for their bioavailability, in-
creased targeting effects, enhanced drug pharmacokinetics, controlled released capabilities
and reduction of drug immunogenicity and toxicity [84]. Microbial based drug carriers are
able to thrive under the hypoxic and acidic pH of the cancer tissue, making them ideal for
targeted cancer therapy [85].
A study used yeast cells for the first time to host hydroxyapatite nanoscaffolds after
the incubation with CaCl2 and Na3PO4 aqueous solutions. The yeast-hydroxyapatite
nanoscaffolds were loaded DOX as a drug model and further functionalized with FA for
targeting purposes (DOX-nHAP@yeasts-FA). The mice infected with hepG2 subcutaneously
showed significant reduction in their tumour volume by DOX-nHAP@yeasts-FA as well as
free DOX. However, the authors highlighted the safety of using DOX-nHAP@yeasts-FA
because of their lower toxicity on normal cells in comparison to the free DOX [86].
The synthesis of GNPs was also reported from recombinant E. coli expressing heavy
metal binding proteins (HMBPs). The biogenic GNPs were found to be safer than conven-
tional synthesized GNPs. Further, the loading of DOX on the biogenic GNPs was done
and demonstrated higher apoptosis rate than the free DOX mainly due to the improved
intracellular uptake as reported by the authors (Figure 6) [87].
Similar to the plant extracts, the use of microbial culture to reduce metal salts and
stabilize the produced MNPs has been reported. Kumar et al. (2014) reported the formation
of spherical GNPs from the Delftia sp., which were loaded with resveratrol. The authors
compared the cytotoxicity of the free and loaded drug against A549 cell line and reported
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65% higher cytotoxicity in case of the loaded resveratrol. Furthermore, the release of
resveratrol from the GNPs was significantly higher at acidic pH conditions, which shows
the increased targeting effect from using these nanocarriers [88].
Figure 6. Synthesis of GNPs from HMBPs expressed by E. coli and subsequent loading of DOX and
its release inside the cells in comparison the free DOX. Reproduced from [87].
Table 1 lists the green components mentioned above. A summary of the different NPs
formulations reviewed herein is included in Table 2.




Alginate • Reduction of metal salts and stabilization of the formed MNPs
CMC
• Improve drug entrapment
• Forms pH responsive nanocomposites
CD
• Increased drug encapsulation
• High thermal and chemical stability
Chitosan
• Can be protonated under acidic media to form pH-responsive
hydrogels
• Can be attracted to negative charged tumour cells in drug delivery
systems
CR
• Interacts with cationic materials due to the presence of anionic
sulphate groups
• Crosslinked with chitosan to prevent burst release of drugs from
hydrogels
Gum
• Reduction of metal salts and stabilization of the formed MNPs
• A scaffold for ligands and drugs
HA • Targeting agent against cancer cells with HA surface receptors
MMt
• Adds mechanical strength to nanocomposites hydrogels
• Improve drug entrapment
• Enhance swelling property of hydrogels
• Control drug release
Phospholipids
• Natural surfactant for preparation of liposomes
• Increase sustained release
Plant extracts • Reduction of metal salts and stabilization of the formed MNPs
Pullulan • Reduction of metal salts and stabilization of the formed MNPs
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Table 2. Summary of the different types of reported green-based nanocarriers.
Formulation Size (nm) * Shape of the NPs/Formulation Composition ** Drug Loaded





141 ± 6 Spherical and ellipsoidal shape CR oligosaccharides/GNPs Epirubicin Increased cytotoxicity [16]
4 for the Fe3O4 NPs Spherical Fe3O4 NPs Fe3O4 NPs/CR/chitosan Methotrexate Controlled release [18]
9.2 ± 1.3 for Fe3O4 NPs (TEM)
Sheet-like matrix with spherical
Fe3O4 NPs
CR/MMt/F3O4 NPs Protocatechuic acid Targeted release [20]
Not reported Irregular and coarse nanogelwith spherical Fe3O4 NPs
CR/m-MMt/chitosan/Fe3O4 NPs Sunitinib Controlled release [19]
<50 (TEM) Dispersed
Fe3O4
NPs/E. cochinchensis leaf extract/mesoporous
silica surface modification with carboxyl groups
DOX Controlled andtargeted release [58]
Nanocomposite
6.4 nm in height (Atomic





171.25 nm in height (AFM) Nanosheet Tea polyphenols/graphene oxide sheets DOX Increased cytotoxicity andtarget release [66]
17 Spherical Black tea aqueous extract/CNPs DOX Increased cytotoxicity andtarget release [67]
202 Spherical EGCG/BSA/FA DOX Increased cytotoxicity andtarget release [75]
225 Spherical Sericin/rice bran albumin/gellan gum DOX Sustained andcontrolled release [24]
Variable sizes (70 ± 30 to
143 ± 36) depending on the
plant extract used
Spherical
S. cumini, B. variegata, C. deodara,
L. japonica and E. sphaericus/
poly(D,L-lactide) NPs
Quercetin Controlled release [48]
375 Spherical Acrysol oil/PLGA NPs resveratrol Increased cytotoxicity andsustained release [49]
120 ± 28 (DLS) Spherical Maltodextrin/gum arabic EGCG Increased cytotoxicity [27]
187 (DLS) Well dispersed Alginate-curcumin/GNPs Methotrexate and curcumin Increased cytotoxicity [36]
80 nm in height (AFM)
Spongy structure withsquare






4–5 mm for wet beads (visual) Spherical CMC/chitosan/ZnONPs 5-FU Controlled release [44]
7–9 mm for wet beads (SEM) Rough surface CMC/layered double hydroxide(zinc/aluminum) 5-FU Controlled release [45]
Variable according to type of
chitosan used Spherical Lecithin/N-trimethyl chitosan DOX
Increased cytotoxicity and
targeting release [82]
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Table 2. Cont.
Formulation Size (nm) * Shape of the NPs/Formulation Composition ** Drug Loaded
Advantage of Using the
Nanocarrier
References
MNPs 20–25 (TEM) Spherical Gum karaya/GNPs gemcitabine hydrochloride Increased cytotoxicity [22]
13 ± 1 (TEM) Spherical Gellan gum/GNPs DOX Increased cytotoxicity [25]
13 ± 5 (TEM) Spherical Porphyran/GNPs DOX Increased cytotoxicity andtargeted release [30]
2–4 (TEM) Spherical Gum kondagogu/PtNPs 5-FU Increased cytotoxicity andsustained release [23]
Variable sizes depending on
incubation time and shape Spherical/hexagonal/triangular E. alba aqueous extract/GNPs DOX Increased cytotoxicity [50]
70.90 ± 8.42 (TEM) Quasi spherical Aqueous peel extract of pomegranate/GNPs/FA 5-FU Increased cytotoxicity [54]
Variable sizes depending on
the type of MNPs and their
shapes
Spherical/hexagonal/triangular
leaf aqueous extract of B. monosperma/GNPs and
leaf aqueous extract of B. monosperma/AgNPs
DOX Increased cytotoxicity [51]
54.2 ± 2.1 (DLS) Spherical Aqueuous leaf extract of P. pterocarpum/GNPs DOX Increased cytotoxicity [52]
5–15 (TEM) Spherical Almond seed water extract/GNPs/PG9 Quercetin Increased cytotoxicity [56]
55 ± 3 (DLS) Spherical eggplant fruit extract/GNPs/HA Metformin Increased cytotoxicity [53]
32.7 ± 5.7 (TEM) Spherical G. mangostana fruit peel extract/AgNPs Protocatechuic acid Increased cytotoxicity [57]
20.9 ± 4.4 (TEM) Spherical Resveratrol/GNPs DOX Increased cytotoxicity [71]
11.35 X-ray diffraction Spherical Tea ethanolic extract/ZnONPs/Chitosan Paclitaxel Targeted release [59]
11.3 (TEM) Spherical Delftia sp. culture broth/GNPs Resveratrol Increased cytotoxicity andtargeted release [88]
5–20 (TEM) Spherical E. coli expressing HMBPs/ GNPs DOX Targeted release [87]
11 ± 5 (TEM) Spherical Pullulan/GNPs Cassiarin A chloridederivatives Increased cytotoxicity [39]
13.7 ± 1.9 (TEM) Spherical para-aminobenzoic acid-quat188-pullulan/GNPs DOX Increased cytotoxicity [40]
12.6 ± 1.5 (TEM) Spherical FA-para-aminobenzoicacid-quat188-pullulan/GNPs DOX Increased cytotoxicity [41]





Nanoethosomes 72.4 ± 4.5 (TEM) Smooth edges and compact 0.2% EGCG, 2% soybean phosphatidylcholine,
30% ethanol, 1% Tween-80 and 0.1% sugar esters
Docetaxel Increased cytotoxicity [81]





* The characterization method is mentioned between brackets. ** The green components(s) are underlined.
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3. Conclusions
Different green components were shown to be key players in the synthesis and in
the function of different types of nanocarriers. The roles of these green components range
from being a scaffold for materials such as drugs or targeting ligand, to the reduction
of metal salts and the stabilization of MNPs. These green components were derived
mainly from plant or microbial sources, which led to the biosynthesis of biocompatibility
nanocarriers with improved safety margin that can allow their use in biological applications.
Furthermore, the shape, size, and stability of green nanocarriers could be optimized by
regulating the pH, reaction temperature, reactants’ concentrations, and time of incubation
during the synthesis. In most of the reports, the green nanocarriers were mainly found to
increase the anticancer activity of the loaded drugs. This was done by having augmented
anticancer properties, by increasing the targeting effect, or by excreting controlled release.
Some reports also formulated pH responsive nanocarriers to take advantage of the different
pH levels between cancer and normal tissues, which can assist in increasing the target
effects of their therapeutic payloads.
There are few challenges that face the potential use of green based nanocarriers in the
market. Similar to other conventional nanomaterials, their synthesis remains complicated
especially with polymeric NPs or liposomes. In addition, there are unsubstantial concerns
of possible allergens or toxicity caused by impurities that can be found on the natural
isolated components such as total plant extracts or natural phospholipids for example.
However, using these natural parts can improve the safety of the nanomaterials. This is
because biodegradable and biocompatible green components can reduce the toxicity that
can arise from the nonbiodegradable residual parts of the conventional drug delivery sys-
tems. The green components can facilitate the synthesis without the need of toxic chemicals
during the preparation of NPs, which improve the safety of the final product. Importantly,
unlike the synthetic materials, these green renewable components will certainly reduce the
cost of the upscaled production for commercial use.
Author Contributions: Conceptualization, A.M.E. and Z.D.; writing—original draft preparation,
A.M.E.; writing—contribution, R.M.M.; writing—review and editing, A.M.E. and Z.D.; supervision
and funding, Z.D. All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by the National Research Foundation of South Africa, Grant
Number PDG200328510718 and the South African Medical Research Council (SAMRC), Grant
Number 23108.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
5-FU—5-fluorouracil; A-375—human melanoma cancer cells; A549—human lung cancer cells;
ACC2—human adenoid cystic carcinoma cell line; AFM—atomic force microscopy; AgNPs—silver
nanoparticles; BSA—bovine serum albumin; C6—rat glioma cell line; CMC—carboxymethylcellulose;
CD—cyclodextrin; CNPs—carbon nanoparticles; CR—carrageenan; DLS—dynamic light scatter-
ing; DOX—doxorubicin; DU145—human androgen independent prostate cancer cells; EGCG—
epigallocatechin-3-gallate; Fe3O4 NPs—iron oxide nanoparticles; FA—folate; GNCs—gold nanoclus-
ters; GNPs—gold nanoparticles; HA—hyaluronic acid; HCT-116—human colon cancer cells; HepG2—
human liver cancer cells; HMBPs—heavy metal binding proteins; K562—human blood cancer cell
line; KATO-III—human gastric carcinoma; MCF-7—breast cancer cells; MDA-MB-231—human
breast cancer cells; m-MMt—magnetic montmorillonite; MMt—montmorillonite; MNPs—metallic
nanoparticles; NIH 3T3—mouse embryonic fibroblast; NPs—nanoparticles; PEG—polyethylene
glycol; PG9—polyethylene glycol 9000; PtNPs—platinum nanoparticles; TEM—transmission electron
microscopy; ZnONPs—zinc oxide nanoparticles.
Cancers 2021, 13, 5686 17 of 20
References
1. Jadoun, S.; Arif, R.; Jangid, N.K.; Meena, R.K. Green synthesis of nanoparticles using plant extracts: A review. Environ. Chem. Lett.
2020, 19, 355–374. [CrossRef]
2. Raliya, R.; Chadha, T.S.; Hadad, K.; Biswas, P. Perspective on nanoparticle technology for biomedical use. Curr. Pharm. Des. 2016,
22, 2481–2490. [CrossRef] [PubMed]
3. Bamrungsap, S.; Zhao, Z.; Chen, T.; Wang, L.; Li, C.; Fu, T.; Tan, W. Nanotechnology in therapeutics: A focus on nanoparticles as a
drug delivery system. Future Med. 2012, 7, 1253–1271. [CrossRef] [PubMed]
4. Ray, P.C. Size and Shape Dependent Second Order Nonlinear Optical Properties of Nanomaterials and Their Application in
Biological and Chemical Sensing. Chem. Rev. 2010, 110, 5332–5365. [CrossRef] [PubMed]
5. Senapati, S.; Mahanta, A.K.; Kumar, S.; Maiti, P. Controlled drug delivery vehicles for cancer treatment and their performance.
Signal Transduct. Target. Ther. 2018, 3, 7. [CrossRef]
6. Ud Din, F.; Aman, W.; Ullah, I.; Qureshi, O.S.; Mustapha, O.; Shafique, S.; Zeb, A. Effective use of nanocarriers as drug delivery
systems for the treatment of selected tumors. Int. J. Nanomed. 2017, 12, 7291–7309. [CrossRef]
7. Liu, Z.; Jiao, Y.; Wang, Y.; Zhou, C.; Zhang, Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv.
Rev. 2008, 60, 1650–1662. [CrossRef] [PubMed]
8. Sak, K. Chemotherapy and Dietary Phytochemical Agents. Chemother. Res. Pract. 2012, 2012, 282570. [CrossRef]
9. Edis, Z.; Wang, J.; Waqas, M.K.; Ijaz, M.; Ijaz, M. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An
Overview and Perspectives. Int. J. Nanomed. 2021, 16, 1313–1330. [CrossRef] [PubMed]
10. Gupta, P.; Garcia, E.; Sarkar, A.; Kapoor, S.; Rafiq, K.; Chand, H.; Jayant, R. Nanoparticle Based Treatment for Cardiovascular
Diseases. Cardiovasc. Hematol. Disord. Drug Targets 2019, 19, 33–44. [CrossRef] [PubMed]
11. Lateef, A.; Ojo, S.A.; Elegbede, J.A. The emerging roles of arthropods and their metabolites in the green synthesis of metallic
nanoparticles. Nanotechnol. Rev. 2016, 5, 601–622. [CrossRef]
12. Zhao, C.; Li, J.; He, B.; Zhao, L. Fabrication of hydrophobic biocomposite by combining cellulosic fibers with polyhydroxyalka-
noate. Cellulose 2017, 24, 2265–2274. [CrossRef]
13. Sinha, V.R.; Kumria, R. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 2001, 224, 19–38. [CrossRef]
14. Chaabouni, E.; Gassara, F.; Brar, S.K. Biopolymers Synthesis and Application. In Biotransformation of Waste Biomass into High Value
Biochemicals; Brar, S.K., Dhillon, G.S., Soccol, C.R., Eds.; Springer: New York, NY, USA, 2014; pp. 415–443.
15. Lee, J.W.; Park, J.H.; Robinson, J.R. Bioadhesive-Based Dosage Forms: The Next Generation. J. Pharm. Sci. 2000, 89, 850–866.
[CrossRef]
16. Chen, X.; Han, W.; Zhao, X.; Tang, W.; Wang, F. Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle
system for pH-triggered anticancer drug release. Sci. Rep. 2019, 9, 6754. [CrossRef] [PubMed]
17. Pavli, M.; Baumgartner, S.; Kos, P.; Kogej, K. Doxazosin-carrageenan interactions: A novel approach for studying drug-polymer
interactions and relation to controlled drug release. Int. J. Pharm. 2011, 421, 110–119. [CrossRef] [PubMed]
18. Mahdavinia, G.; Mosallanezhad, A.; Soleymani, M.; Sabzi, M. Magnetic- and pH-responsive -carrageenan/chitosan complexes
for controlled release of methotrexate anticancer drug. Int. J. Biol. Macromol. 2017, 97, 209–217. [CrossRef] [PubMed]
19. Jafari, H.; Atlasi, Z.; Mahdavinia, G.R.; Hadifar, S.; Sabzi, M. Magnetic -carrageenan/chitosan/montmorillonite nanocomposite
hydrogels with controlled sunitinib release. Mater. Sci. Eng. C 2021, 124, 112042. [CrossRef] [PubMed]
20. Yew, Y.P.; Shameli, K.; Mohamad, S.E.; Lee, K.X.; Teow, S.-Y. Green Synthesized Montmorillonite/Carrageenan/Fe3O4 Nanocom-
posites for pH-Responsive Release of Protocatechuic Acid and Its Anticancer Activity. Int. J. Mol. Sci. 2020, 21, 4851. [CrossRef]
21. Donadelli, M.; Costanzo, C.; Beghelli, S.; Scupoli, M.; Dandrea, M.; Bonora, A.; Piacentini, P.; Budillon, A.; Caraglia, M.; Scarpa,
A.; et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. Biochim. Biophys.
Acta 2007, 1773, 1095–1106. [CrossRef] [PubMed]
22. Pooja, D.; Panyaram, S.; Kulhari, H.; Reddy, B.; Rachamalla, S.S.; Sistla, R. Natural polysaccharide functionalized gold nanoparti-
cles as biocompatible drug delivery carrier. Int. J. Biol. Macromol. 2015, 80, 48–56. [CrossRef] [PubMed]
23. Godugu, D.; Beedu, S. Synthesis, characterisation and anti-tumour activity of biopolymer based platinum nanoparticles and
5-fluorouracil loaded platinum nanoparticles. IET Nanobiotechnol. 2019, 13, 282–292. [CrossRef] [PubMed]
24. Arjama, M.; Mehnath, S.; Rajan, M.; Jeyaraj, M. Sericin/RBA embedded gellan gum based smart nanosystem for pH responsive
drug delivery. Int. J. Biol. Macromol. 2018, 120, 1561–1571. [CrossRef] [PubMed]
25. Dhar, S.; Reddy, E.; Shiras, A.; Pokharkar, V.; Prasad, B. Natural gum reduced/stabilized gold nanoparticles for drug delivery
formulations. Chemistry 2008, 14, 10244–10250. [CrossRef]
26. Barthold, S.; Hittinger, M.; Primavessy, D.; Zapp, A.; Groß, H.; Schneider, M. Preparation of maltodextrin nanoparticles and
encapsulation of bovine serum albumin-Influence of formulation parameters. Eur. J. Pharm. Biopharm. 2019, 142, 405–410.
[CrossRef] [PubMed]
27. Rocha, S.; Generalov, R.; Pereira Mdo, C.; Peres, I.; Juzenas, P.; Coelho, M. Epigallocatechin gallate-loaded polysaccharide
nanoparticles for prostate cancer chemoprevention. Nanomedicine 2011, 6, 79–87. [CrossRef] [PubMed]
28. Bhatia, S.; Rathee, P.; Sharma, K.; Chaugule, B.B.; Kar, N.; Bera, T. Immuno-modulation effect of sulphated polysaccharide
(porphyran) from Porphyra vietnamensis. Int. J. Biol. Macromol. 2013, 57, 50–56. [CrossRef] [PubMed]
Cancers 2021, 13, 5686 18 of 20
29. He, D.; Wu, S.; Yan, L.; Zuo, J.; Cheng, Y.; Wang, H.; Liu, J.; Zhang, X.; Wu, M.; Choi, J.; et al. Antitumor bioactivity of porphyran
extracted from Pyropia yezoensis Chonsoo2 on human cancer cell lines. J. Sci. Food Agric. 2019, 99, 6722–6730. [CrossRef]
[PubMed]
30. Venkatpurwar, V.; Shiras, A.; Pokharkar, V. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer
drug: In vitro cytotoxicity study. Int. J. Pharm. 2011, 409, 314–320. [CrossRef] [PubMed]
31. Gadade, D.D.; Pekamwar, S.S. Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics. Adv. Pharm. Bull. 2020, 10,
166–183. [CrossRef] [PubMed]
32. Zhang, Y.-M.; Cao, Y.; Yang, Y.; Chen, J.-T.; Liu, Y. A small-sized graphene oxide supramolecular assembly for targeted delivery of
camptothecin. Chem. Commun. 2014, 50, 13066–13069. [CrossRef] [PubMed]
33. Qiu, C.; Wang, J.; Zhang, H.; Qin, Y.; Xu, X.; Jin, Z. Novel Approach with Controlled Nucleation and Growth for Green Synthesis
of Size-Controlled Cyclodextrin-Based Metal-Organic Frameworks Based on Short-Chain Starch Nanoparticles. J. Agric. Food
Chem. 2018, 66, 9785–9793. [CrossRef] [PubMed]
34. Hosseini, S.M.; Hosseini, H.; Mohammadifar, M.A.; Mortazavian, A.M.; Mohammadi, A.; Khosravi-Darani, K.; Shojaee-Aliabadi,
S.; Dehghan, S.; Khaksar, R. Incorporation of essential oil in alginate microparticles by multiple emulsion/ionic gelation process.
Int. J. Biol. Macromol. 2013, 62, 582–588. [CrossRef]
35. Zhao, X.; Li, Z.; Deng, Y.; Zhao, Z.; Li, X.; Xia, Y. Facile Synthesis of Gold Nanoparticles with Alginate and Its Catalytic Activity
for Reduction of 4-Nitrophenol and H2O2 Detection. Materials 2017, 10, 557. [CrossRef]
36. Dey, S.; Sherly, M.C.D.; Rekha, M.R.; Sreenivasan, K. Alginate stabilized gold nanoparticle as multidrug carrier: Evaluation of
cellular interactions and hemolytic potential. Carbohydr. Polym. 2016, 136, 71–80. [CrossRef]
37. Catley, B.J.; Ramsay, A.; Servis, C. Observations on the structure of the fungal extracellular polysaccharide, pullulan. Carbohydr.
Res. 1986, 153, 79–86. [CrossRef]
38. Choudhury, A.R.; Malhotra, A.; Bhattacharjee, P.; Prasad, G.S. Facile and rapid thermo-regulated biomineralization of gold by
pullulan and study of its thermodynamic parameters. Carbohydr. Polym. 2014, 106, 154–159. [CrossRef] [PubMed]
39. Laksee, S.; Puthong, S.; Teerawatananond, T.; Palaga, T.; Muangsin, N. Highly efficient and facile fabrication of monodispersed Au
nanoparticles using pullulan and their application as anticancer drug carriers. Carbohydr. Polym. 2017, 173, 178–191. [CrossRef]
[PubMed]
40. Laksee, S.; Puthong, S.; Kongkavitoon, P.; Palaga, T.; Muangsin, N. Facile and green synthesis of pullulan derivative-stabilized
Au nanoparticles as drug carriers for enhancing anticancer activity. Carbohydr. Polym. 2018, 198, 495–508. [CrossRef] [PubMed]
41. Laksee, S.; Sansanaphongpricha, K.; Puthong, S.; Sangphech, N.; Palaga, T.; Muangsin, N. New organic/inorganic nanohybrids of
targeted pullulan derivative/gold nanoparticles for effective drug delivery systems. Int. J. Biol. Macromol. 2020, 162, 561–577.
[CrossRef] [PubMed]
42. Yadollahi, M.; Gholamali, I.; Namazi, H.; Aghazadeh, M. Synthesis and characterization of antibacterial carboxymethyl cellu-
lose/ZnO nanocomposite hydrogels. Int. J. Biol. Macromol. 2015, 74, 136–141. [CrossRef]
43. Javanbakht, S.; Pooresmaeil, M.; Namazi, H. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic
framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system. Carbohydr. Polym. 2019, 208, 294–301.
[CrossRef] [PubMed]
44. Sun, X.; Liu, C.; Omer, A.; Lu, W.; Zhang, S.; Jiang, X.; Wu, H.; Yu, D.; Ouyang, X. pH-sensitive ZnO/carboxymethyl cellu-
lose/chitosan bio-nanocomposite beads for colon-specific release of 5-fluorouracil. Int. J. Biol. Macromol. 2019, 128, 468–479.
[CrossRef] [PubMed]
45. Pooresmaeil, M.; Behzadi Nia, S.; Namazi, H. Green encapsulation of LDH(Zn/Al)-5-Fu with carboxymethyl cellulose biopolymer;
new nanovehicle for oral colorectal cancer treatment. Int. J. Biol. Macromol. 2019, 139, 994–1001. [CrossRef]
46. Mansur, A.A.P.; Amaral-Júnior, J.C.; Carvalho, S.M.; Carvalho, I.C.; Mansur, H.S. Cu-In-S/ZnS@carboxymethylcellulose
supramolecular structures: Fluorescent nanoarchitectures for targeted-theranostics of cancer cells. Carbohydr. Polym. 2020,
247, 116703. [CrossRef] [PubMed]
47. Samarehfekri, H.; Rahimi, H.R.; Ranjbar, M. Controlled and cellulose eco-friendly synthesis and characterization of Bi2O2CO3
quantum dot nanostructures (QDNSs) and drug delivery study. Sci. Rep. 2020, 10, 21302. [CrossRef] [PubMed]
48. Kumari, A.; Kumar, V.; Yadav, S.K. Plant Extract Synthesized PLA Nanoparticles for Controlled and Sustained Release of
Quercetin: A Green Approach. PLoS ONE 2012, 7, e41230. [CrossRef]
49. Kumar, S.; Lather, V.; Pandita, D. A facile green approach to prepare core-shell hybrid PLGA nanoparticles for resveratrol delivery.
Int. J. Biol. Macromol. 2016, 84, 380–384. [CrossRef]
50. Mukherjee, S.; Sushma, V.; Patra, S.; Barui, A.K.; Bhadra, M.P.; Sreedhar, B.; Patra, C.R. Green chemistry approach for the synthesis
and stabilization of biocompatible gold nanoparticles and their potential applications in cancer therapy. Nanotechnology 2012, 23,
455103. [CrossRef] [PubMed]
51. Patra, S.; Mukherjee, S.; Barui, A.K.; Ganguly, A.; Sreedhar, B.; Patra, C.R. Green synthesis, characterization of gold and silver
nanoparticles and their potential application for cancer therapeutics. Mater. Sci. Eng. C 2015, 53, 298–309. [CrossRef]
52. Mukherjee, S.; Sau, S.; Madhuri, D.; Bollu, V.; Madhusudana, K.; Sreedhar, B.; Banerjee, R.; Patra, C. Green Synthesis and
Characterization of Monodispersed Gold Nanoparticles: Toxicity Study, Delivery of Doxorubicin and Its Bio-Distribution in
Mouse Model. J. Biomed. Nanotechnol. 2016, 12, 165–181. [CrossRef] [PubMed]
Cancers 2021, 13, 5686 19 of 20
53. Kumar, C.S.; Raja, M.D.; Sundar, D.S.; Gover Antoniraj, M.; Ruckmani, K. Hyaluronic acid co-functionalized gold nanoparticle
complex for the targeted delivery of metformin in the treatment of liver cancer (HepG2 cells). Carbohydr. Polym. 2015, 128, 63–74.
[CrossRef] [PubMed]
54. Ganeshkumar, M.; Sathishkumar, M.; Ponrasu, T.; Dinesh, M.G.; Suguna, L. Spontaneous ultra fast synthesis of gold nanoparticles
using Punica granatum for cancer targeted drug delivery. Colloids Surf. B Biointerfaces 2013, 106, 208–216. [CrossRef]
55. Chinnaiyan, S.; Soloman, A.; Perumal, R.; Gopinath, A.; Balaraman, M. 5 Fluorouracil-loaded biosynthesised gold nanoparticles
for the in vitro treatment of human pancreatic cancer cell. IET Nanobiotechnol. 2019, 13, 824–828. [CrossRef]
56. Sadalage, P.S.; Patil, R.V.; Havaldar, D.V.; Gavade, S.S.; Santos, A.C.; Pawar, K.D. Optimally biosynthesized, PEGylated
gold nanoparticles functionalized with quercetin and camptothecin enhance potential anti-inflammatory, anti-cancer and anti-
angiogenic activities. J. Nanobiotechnol. 2021, 19, 84. [CrossRef]
57. Lee, K.X.; Shameli, K.; Mohamad, S.E.; Yew, Y.P.; Isa, E.D.M.; Yap, H.-Y.; Lim, W.L.; Teow, S.-Y. Bio-Mediated Synthesis and
Characterisation of Silver Nanocarrier, and Its Potent Anticancer Action. Nanomaterials 2019, 9, 1432. [CrossRef] [PubMed]
58. Cai, W.; Guo, M.; Weng, X.; Zhang, W.; Owens, G.; Chen, Z. Modified green synthesis of Fe3O4@SiO2 nanoparticles for pH
responsive drug release. Mater. Sci. Eng. C 2020, 112, 110900. [CrossRef] [PubMed]
59. Akbarian, M.; Mahjoub, S.; Elahi, S.; Zabihi, E.; Tashakkorian, H. Green synthesis, formulation and biological evaluation of a novel
ZnO nanocarrier loaded with paclitaxel as drug delivery system on MCF-7 cell line. Colloids Surf. B Biointerfaces 2020, 186, 110686.
[CrossRef]
60. Liu, H.; Zhang, X.; Xu, Z.; Wang, Y.; Ke, Y.; Jiang, Z.; Yuan, Z.; Li, H. Role of polyphenols in plant-mediated synthesis of gold
nanoparticles: Identification of active components and their functional mechanism. Nanotechnology 2020, 31, 415601. [CrossRef]
61. Wang, Z.; Fang, C.; Megharaj, M. Characterization of Iron–Polyphenol Nanoparticles Synthesized by Three Plant Extracts and
Their Fenton Oxidation of Azo Dye. ACS Sustain. Chem. Eng. 2014, 2, 1022–1025. [CrossRef]
62. Swilam, N.; Nematallah, K.A. Polyphenols profile of pomegranate leaves and their role in green synthesis of silver nanoparticles.
Sci. Rep. 2020, 10, 14851. [CrossRef]
63. Huang, X.; Wu, H.; Liao, X.; Shi, B. One-step, size-controlled synthesis of gold nanoparticles at room temperature using plant
tannin. Green Chem. 2010, 12, 395–399. [CrossRef]
64. Mao, H.; Liao, Y.; Ma, J.; Zhao, S.L.; Huo, F.W. Water-soluble metal nanoparticles stabilized by plant polyphenols for improving
the catalytic properties in oxidation of alcohols. Nanoscale 2015, 8, 1049–1054. [CrossRef]
65. Jiang, X.; Sun, Y.; Shang, L.; Yang, C.; Kong, L.; Zhang, Z. Green tea extract-assembled nanoclusters for combinational photother-
mal and chemotherapy. J. Mater. Chem. B 2019, 7, 5972–5982. [CrossRef]
66. Wang, X.; Hao, L.; Zhang, C.; Chen, J.; Zhang, P. High efficient anti-cancer drug delivery systems using tea polyphenols reduced
and functionalized graphene oxide. J. Biomater. Appl. 2017, 31, 1108–1122. [CrossRef] [PubMed]
67. Bayda, S.; Hadla, M.; Palazzolo, S.; Kumar, V.; Caligiuri, I.; Ambrosi, E.; Pontoglio, E.; Agostini, M.; Tuccinardi, T.; Benedetti,
A.; et al. Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy. J. Control. Release 2017, 248, 144–152.
[CrossRef]
68. Rauf, A.; Imran, M.; Butt, M.; Nadeem, M.; Peters, D.; Mubarak, M. Resveratrol as an anti-cancer agent: A review. Crit. Rev. Food
Sci. Nutr. 2018, 58, 1428–1447. [CrossRef] [PubMed]
69. Athar, M.; Back, J.H.; Tang, X.; Kim, K.H.; Kopelovich, L.; Bickers, D.R.; Kim, A.L. Resveratrol: A review of preclinical studies for
human cancer prevention. Toxicol. Appl. Pharmacol. 2007, 224, 274–283. [CrossRef]
70. Güder, A.; Korkmaz, H.; Gökce, H.; Alpaslan, Y.B.; Alpaslan, G. Isolation, characterization, spectroscopic properties and quantum
chemical computations of an important phytoalexin resveratrol as antioxidant component from Vitis labrusca L. and their
chemical compositions. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2014, 133, 378–395. [CrossRef] [PubMed]
71. Tomoaia, G.; Horovitz, O.; Mocanu, A.; Nita, A.; Avram, A.; Racz, C.P.; Soritau, O.; Cenariu, M.; Tomoaia-Cotisel, M. Effects of
doxorubicin mediated by gold nanoparticles and resveratrol in two human cervical tumor cell lines. Colloids Surf. B Biointerfaces
2015, 135, 726–734. [CrossRef] [PubMed]
72. Bandyopadhyay, P.; Ghosh, A.; Ghosh, C. Recent developments on polyphenol–protein interactions: Effects on tea and coffee
taste, antioxidant properties and the digestive system. Food Funct. 2012, 3, 592–605. [CrossRef]
73. Liang, K.; Ng, S.; Lee, F.; Lim, J.; Chung, J.; Lee, S.; Kurisawa, M. Targeted intracellular protein delivery based on hyaluronic
acid-green tea catechin nanogels. Acta Biomater. 2016, 33, 142–152. [CrossRef]
74. Bae, K.; Tan, S.; Yamashita, A.; Ang, W.; Gao, S.; Wang, S.; Chung, J.; Kurisawa, M. Hyaluronic acid-green tea catechin micellar
nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity. Biomaterials 2017,
148, 41–53. [CrossRef] [PubMed]
75. Zhang, J.; Ren, X.; Tian, X.; Zhang, P.; Chen, Z.; Hu, X.; Mei, X. GSH and enzyme responsive nanospheres based on self-assembly
of green tea polyphenols and BSA used for target cancer chemotherapy. Colloids Surf. B. Biointerfaces 2019, 173, 654–661. [CrossRef]
76. Soreide, K.; Janssen, E.; Körner, H.; Baak, J. Trypsin in colorectal cancer: Molecular biological mechanisms of proliferation,
invasion, and metastasis. J. Pathol. 2006, 209, 147–156. [CrossRef] [PubMed]
77. Lv, H.; Zhen, C.; Liu, J.; Yang, P.; Hu, L.; Shang, P. Unraveling the potential role of glutathione in multiple forms of cell death in
cancer therapy. Oxid. Med. Cell. Longev. 2019, 2019, 3150145. [CrossRef] [PubMed]
78. Van Hoogevest, P.; Wendel, A. The use of natural and synthetic phospholipids as pharmaceutical excipients. Eur. J. Lipid Sci.
Technol. 2014, 116, 1088–1107. [CrossRef] [PubMed]
Cancers 2021, 13, 5686 20 of 20
79. Huang, C. Mixed-chain phospholipids: Structures and chain-melting behavior. Lipids 2001, 36, 1077–1097. [CrossRef] [PubMed]
80. Abdelmoneim, H.A.; Xiaoqiang, Z.; Sherif, M.A.; Sameh, A.K.; Qingzhe, J.; Xingguo, W. Natural phospholipids: Occurrence,
biosynthesis, separation, identification, and beneficial health aspects. Crit. Rev. Food Sci. Nutr. 2017, 59, 253–275. [CrossRef]
81. Liao, B.; Ying, H.; Yu, C.; Fan, Z.; Zhang, W.; Shi, J.; Ying, H.; Ravichandran, N.; Xu, Y.; Yin, J.; et al. (-)-Epigallocatechin gallate
(EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
Int. J. Pharm. 2016, 512, 22–31. [CrossRef] [PubMed]
82. Guo, X.-X.; He, W.; Wang, X.-Q.; Hu, X.-M. Preparation and efficacy of tumor vasculature-targeted doxorubicin cationic liposomes
coated by N-trimethyl chitosan. J. Appl. Polym. Sci. 2011, 121, 2149–2156. [CrossRef]
83. Zhang, Y.; Zhu, W.; Zhang, H.; Han, J.; Zhang, L.; Lin, Q.; Ai, F. Carboxymethyl chitosan/phospholipid bilayer-capped
mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug,
Docetaxel. Int. J. Pharm. 2017, 532, 384–392. [CrossRef] [PubMed]
84. Pierigè, F.; Serafini, S.; Rossi, L.; Magnani, M. Cell-based drug delivery. Adv. Drug Deliv. Rev. 2008, 60, 286–295. [CrossRef]
85. Luo, C.; Huang, C.; Su, C.; Yeh, C. Bacteria-Mediated Hypoxia-Specific Delivery of Nanoparticles for Tumors Imaging and
Therapy. Nano Lett. 2016, 16, 3493–3499. [CrossRef]
86. Ma, X.; Liu, P.; Tian, Y.; Zhu, G.; Yang, P.; Wang, G.; Yang, L. A mineralized cell-based functional platform: Construction of yeast
cells with biogenetic intracellular hydroxyapatite nanoscaffolds. Nanoscale 2018, 10, 3489–3496. [CrossRef]
87. Seo, J.M.; Kim, E.B.; Hyun, M.S.; Kim, B.B.; Park, T.J. Self-assembly of biogenic gold nanoparticles and their use to enhance drug
delivery into cells. Colloids Surf. B Biointerfaces 2015, 135, 27–34. [CrossRef]
88. Ganesh Kumar, C.; Poornachandra, Y.; Mamidyala, S.K. Green synthesis of bacterial gold nanoparticles conjugated to resveratrol
as delivery vehicles. Colloids Surf. B Biointerfaces 2014, 123, 311–317. [CrossRef]
View publication stats
